Posts

Virtual Nursing Programs Are Transforming Patient Care

Virtual nursing programs leverage technology, enhance access, and improve efficiency to revolutionize patient care. Medscape Medical News source https://www.medscape.com/viewarticle/virtual-nursing-programs-are-transforming-patient-care-2025a10007zt?src=rss

Intermittent Fasting Beats Calorie Cutting for Weight Loss

A 4:3 nonconsecutive intermittent fasting regimen was more tolerable and yielded somewhat greater weight loss at 1 year than daily caloric restriction. Medscape Medical News source https://www.medscape.com/viewarticle/intermittent-fasting-outperforms-daily-calorie-cutting-2025a10007vw?src=rss

Multiple Drug Initiations Common Despite Limited Evidence

A recent study shows that primary care physicians often initiate multiple medications simultaneously despite limited supporting evidence, with notable variations across prescribers and institutions. Medscape Medical News source https://www.medscape.com/viewarticle/multiple-drug-initiations-common-despite-limited-evidence-2025a10007vu?src=rss

Hormonal Contraceptives and Allergies: Is There a Link?

The use of systemic hormonal contraceptives may be associated with an elevated risk for allergic rhinitis, a recent study shows. Medscape Medical News source https://www.medscape.com/viewarticle/hormonal-contraceptives-and-allergies-there-link-2025a10007vg?src=rss

Don’t Overlook Processed Meat as CRC Risk Factor

By addressing this often-underappreciated dietary factor, physicians can promote awareness and healthier eating habits, ultimately contributing to improved colorectal health among their patients. Medscape Medical News source https://www.medscape.com/viewarticle/dont-overlook-processed-meat-colorectal-cancer-risk-factor-2025a10007vd?src=rss

FDA Okays Perioperative Durvalumab for Bladder Cancer

Approval was based on improved survival outcomes vs platinum-based chemotherapy as demonstrated in the phase 3 NIAGARA study. Medscape Medical News source https://www.medscape.com/viewarticle/fda-okays-perioperative-durvalumab-regimen-muscle-invasive-2025a10007rs?src=rss